Volume 11,Issue 2
Effects of Insulin Pump-enhanced Hypoglycemic Control on Blood Glucose and Lipid Metabolism in Patients with First-onset Type 2 Diabetes
Objective: To analyze the effect of intensive hypoglycemic treatment with insulin pump on blood glucose and lipid metabolism levels in patients with new-onset type 2 diabetes. Methods: From January to December 2024, 80 patients with new-onset type 2 diabetes were selected for data analysis in our hospital. They were divided into groups using a random number table, with 40 patients in each group. The research group was treated with an insulin pump for intensive hypoglycemic treatment, and the control group was treated with routine subcutaneous injection of insulin aspart. The data between the groups were compared. Results: Compared with the control group, the blood sugar of the study group was significantly lower after treatment, TC, TG and LDL-C were significantly lower after treatment, and HDL-C was significantly higher after treatment, p < 0.05; compared with the two groups before treatment, blood sugar, TC, TG, LDL-C and HDL-C were significantly lower, p > 0.05. Conclusion: Patients with first-onset type 2 diabetes are treated with intensive hypoglycemic treatment using insulin pumps. After treatment, their blood sugar is significantly lower. After treatment, TC, TG and LDL-C are all significantly lower. After treatment, HDL-C is significantly higher. It is worthy of clinical promotion and use.
[1] Zhong R, Li Y, Yuan X, et al., 2025, The Therapeutic Effect of Short-Term Intensive Treatment with Dapagliflozin Combined with Insulin Pump on Patients with New-Onset Type 2 Diabetes. Diabetes New World, 28(15): 14–17.
[2] Ouyang L, Huang Z, Qiu X, 2025, Effect of Short-Term Insulin Pump Intensive Therapy on Refractory Type 2 Diabetes. Diabetes New World, 28(14): 73–76.
[3] Wang X, 2023, Effects of Insulin Pump-Enhanced Hypoglycemic Control on Metabolic Indexes in Patients with First-Onset Type 2 Diabetes. Liaoning Medical Journal, 37(4): 64–66.
[4] Tang Q, 2025, Effects of Liraglutide Combined with Insulin Pump Intensive Therapy on Blood Sugar, Blood Lipids and Adverse Reactions in Newly Diagnosed Patients with Type 2 Diabetes. Clinical Medical Research and Practice, 10(15): 78–81.
[5] Wang X, 2025, Application Effect of Dapagliflozin Combined with Metformin after Short-Term Intensive Insulin Pump Treatment in Overweight and Obese Patients with Newly Diagnosed Type 2 Diabetes. Clinical Medicine, 45(5): 92–94.
[6] Zhou D, Zhou Z, 2025, Comparison of the Efficacy and Impact of Insulin Pump Intensive Treatment of Dapagliflozin and Metformin in Patients with Type 2 Diabetes. Clinical Rational Drug Use, 18(12): 1–4.
[7] Zeng X, Li Y, 2025, Effects of Short-Term Intensive Treatment with Dapagliflozin Combined with Insulin Pump on Blood Sugar and Pancreatic Beta Cell Function in Patients with Type 2 Diabetes. Drug Evaluation, 22(3): 326–329.
[8] Zhang W, Zhang Y, Tang J, et al., 2023, Effects of Insulin Pump-Enhanced Hypoglycemic Control on Blood Sugar and Lipid Metabolism Levels in Patients with First-Onset Type 2 Diabetes. Clinical Medical Engineering, 30(11): 1499–1500.